Humanigen Hits Ch. 11 After COVID Drug Denied Authorization
After failing to receive emergency authorization for a COVID-19 treatment, drug developer Humanigen Inc. filed for Chapter 11 bankruptcy in Delaware with $44.1 million in unsecured debt and plans to pursue...To view the full article, register now.
Already a subscriber? Click here to view full article